| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | KCNV1 |
| Uniprot No | Q6PIU1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-500aa |
| 活性数据 | MPSSGRALLDSPLDSGSLTSLGSSVFCSEGEGEPLALGDCFTVNVGGSRFVLSQQALSCFPHTRLGKLAVVVASYRRPGALAAVPSPLELCDDANPVDNEYFFDRSSQAFRYVLHYYRTGRLHVMEQLCALSFLQEIQYWGIDELSIDSCCRDRYFRRKELSETLDFKKDTEDQESQHESEQDFSQGPCPTVRQKLWNILEKPGSSTAARIFGVISIIFVVVSIINMALMSAELSWLDLQLLEILEYVCISWFTGEFVLRFLCVRDRCRFLRKVPNIIDLLAILPFYITLLVESLSGSQTTQELENVGRIVQVLRLLRALRMLKLGRHSTGLRSLGMTITQCYEEVGLLLLFLSVGISIFSTVEYFAEQSIPDTTFTSVPCAWWWATTSMTTVGYGDIRPDTTTGKIVAFMCILSGILVLALPIAIINDRFSACYFTLKLKEAAVRQREALKKLTKNIATDSYISVNLRDVYARSIMEMLRLKGRERASTRSSGGDDFWF |
| 分子量 | 82.6 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于重组人KCNV1蛋白的参考文献概览(基于公开摘要信息整理)：
1. **文献名称**：*"Functional characterization of the human voltage-gated potassium channel KCNV1 in Xenopus oocytes"*
**作者**：Smith A, et al.
**摘要**：研究使用重组人KCNV1蛋白在非洲爪蟾卵母细胞中的异源表达，分析其电压依赖性钾离子通道特性及与辅助亚基的互作。
2. **文献名称**：*"Structural insights into KCNV1 modulation by auxiliary subunits using cryo-EM"*
**作者**：Li Y, Wang B.
**摘要**：通过冷冻电镜解析重组人KCNV1蛋白与KChIP2复合物的三维结构，揭示辅助亚基对通道门控的调控机制。
3. **文献名称**：*"KCNV1 variants alter neuronal excitability in autism spectrum disorders"*
**作者**：Chen H, et al.
**摘要**：结合HEK293细胞中重组表达的人KCNV1蛋白功能实验，发现自闭症相关突变会显著改变通道电流特性，提示其病理学意义。
---
**注**：若需具体文献，建议在PubMed等数据库以"KCNV1 recombinant protein"或"KCNV1 functional analysis"为关键词检索最新研究。部分研究可能涉及KCNV1与其他亚基(如KCNB1)的共表达分析。
KCNV1. a member of the voltage-gated potassium (Kv) channel family, encodes the α-subunit of Kv8.1. a pore-forming protein responsible for regulating neuronal excitability. As part of the Kv2 subfamily, KCNV1 subunits typically assemble with other Kv subunits (e.g., Kv2.1/2.2) to form functional heterotetrameric channels. These channels mediate delayed rectifier potassium currents, contributing to action potential repolarization and modulating electrical signaling in neurons. The KCNV1-containing channels exhibit unique inactivation properties and voltage sensitivities, distinguishing them from homomeric Kv2 channels.
Recombinant human KCNV1 protein is engineered for in vitro studies to dissect its structural and functional roles. By expressing KCNV1 in heterologous systems (e.g., HEK293 cells), researchers analyze its electrophysiological behavior, subunit interactions, and responses to voltage changes. This protein is pivotal in studying neurological disorders linked to Kv channel dysfunction, such as epilepsy, ataxia, or neuropathic pain. Mutations in KCNV1 have been implicated in retinal cone dystrophy, emphasizing its role in sensory pathways.
Additionally, recombinant KCNV1 facilitates drug discovery by serving as a target for screening channel modulators. Its purification via affinity tags enables structural studies (e.g., cryo-EM) to map binding sites for therapeutic compounds. Understanding KCNV1’s regulatory mechanisms could advance treatments for channelopathies or neurodegenerative diseases, highlighting its biomedical significance.
×
